News

We are pleased to announce Metrum Research Group's new business offering, Strategic Advisory Solutions. With over two decades of excellence in quantitative approaches to drug development, MetrumRG is advancing these strategies to enterprise-level decision making through this newly formed service.

In an increasingly complex and competitive landscape, pharmaceutical and biotech companies face numerous challenges in optimizing the path from discovery to successful commercialization. Despite the emergence of new targets and novel treatment modalities, diseases remain difficult to defeat. With longer development timelines, rising R&D costs, and increased uncertainty in product differentiation, regulatory expectations, and reimbursement,  medicine failure rates remain high. There is a need to develop optimal, data-driven decision making frameworks to drive portfolio-wide development and investment strategies.

MetrumRG’s Strategic Advisory Solutions address this need with a team of experienced leaders who provide quantitative assessments of programs and portfolios, supported by quantitative science and innovative technology. This offering delivers expert guidance to biopharma leaders, empowering them to make data-driven decisions with confidence. Whether optimizing development plans, assessing decision quality, understanding portfolio risk, navigating complex regulatory environments, or maximizing product value, we deliver tailored, strategic solutions designed to meet the unique needs of each client. 

Our Strategic Advisory Solutions address a variety of drug development needs, including:

• Business development recommendations for in/out licensing and for optimal product representation to potential partners
• Data-driven asset differentiation in competitive therapeutic areas
• Dynamic portfolio prioritization based on ongoing assessment of likelihood of assets achieving their target product profiles 
• Integration of enterprise-wide data science/scientist strategies to inform medicines development
• Technical and regulatory risk assessment for medicine programs
• Quantitative market evaluations anchored on target product profiles and emerging understanding of product benefit and risk
• Implementation of durable and reproducible enterprise-wide decision quality frameworks 
• Model-informed drug development guidance
• Scientific advisory committee participation

For more information about Strategic Advisory Solutions, please contact us

About Metrum Research Group

At Metrum Research Group, we are committed to accelerating impact through scientific excellence and innovative technology solutions. For over 20 years, we’ve partnered with companies across the globe, empowering them with the tools and insights they need to drive success in drug development.